 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/18/2018 |
$99.15 |
$99.33 |
$98.31 |
$98.48 |
6.43M | | 06/19/2018 |
$97.89 |
$98.38 |
$96.93 |
$98.01 |
5.53M | | 06/20/2018 |
$98.22 |
$99.55 |
$97.84 |
$98.25 |
5.84M | | 06/21/2018 |
$97.71 |
$97.99 |
$95.26 |
$95.55 |
7.22M | | 06/22/2018 |
$96.06 |
$96.11 |
$93.43 |
$93.49 |
9.45M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on June 18, 2018, ABBV opened at $99.15, traded as high as $99.33 and as low as $98.31, and closed at $98.48. Trading volume was a total of 6.43M shares. On June 19, 2018, ABBV opened at $97.89, traded as high as $98.38 and as low as $96.93, and closed at $98.01. Trading volume was a total of 5.53M shares. On June 20, 2018, ABBV opened at $98.22, traded as high as $99.55 and as low as $97.84, and closed at $98.25. Trading volume was a total of 5.84M shares. On June 21, 2018, ABBV opened at $97.71, traded as high as $97.99 and as low as $95.26, and closed at $95.55. Trading volume was a total of 7.22M shares. On June 22, 2018, ABBV opened at $96.06, traded as high as $96.11 and as low as $93.43, and closed at $93.49. Trading volume was a total of 9.45M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
06/22/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$93.49 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
346.43 |
|
| Dividends reinvested/share: |
$11.79 |
|
| Total return: |
223.88% |
|
| Average Annual Total Return: |
23.97% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$32,381.82 |
|
| Years: |
5.47 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
06/22/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$93.49 |
|
| Dividends collected/share: |
$11.79 |
|
| Total return: |
199.77% |
|
| Average Annual Total Return: |
22.23% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,973.07 |
|
| Years: |
5.47 |
|
|
|
| Date |
Close |
| 06/18/2018 | $98.48 | | 06/19/2018 | $98.01 | | 06/20/2018 | $98.25 | | 06/21/2018 | $95.55 | | 06/22/2018 | $93.49 |
|
|
